next generation semaglutide GLP-1 Therapies for Obesity: Weight Loss Outcomes and Safety | Ney Carter Borges MD M.Sc. Ph.D FESC,FACC,FAHA,FACP. posted on the topic If retatrutide isn't FDA approved

What is the recommended subcutaneous dose of glutathione?

Action of Metformin therapy against advanced glycation, oxidative stress and inflammation in type 2 diabetes patients: 3 months follow-up study

C-reactive protein reduction High-sensitivity C-reactive protein, or hsCRP, is one of the primary markers rheumatologists use to track inflammation in lupus patients

Using them purely for cosmetic weight loss while high-risk patients cannot access those, raises ethical and healthcare equity concerns.Is there a danger that patients may stop statins, BP medicines, or lifestyle measures thinking GLP-1 is a magic bullet?Yes, that is a real concern

Sermorelin is a GHRH analog